Company Analysis MatsukiyoCocokara & Co.
1. Summary
Advantages
- The company's current efficiency (ROE=10.5%) is higher than the sector average (ROE=-9.9%)
Disadvantages
- Price (2376.5 Β₯) is higher than fair price (1254.96 Β₯)
- Dividends (2.02%) are below the sector average (2.69%).
- The stock's return over the last year (-2.74%) is lower than the sector average (0.1167%).
- Current debt level 2.85% has increased over 5 years from 1.82%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
MatsukiyoCocokara & Co. | Healthcare | Index | |
---|---|---|---|
7 days | 1.2% | 0% | -5.3% |
90 days | 3.8% | 0% | -10.7% |
1 year | -2.7% | 0.1% | -11.3% |
3088 vs Sector: MatsukiyoCocokara & Co. has slightly underperformed the "Healthcare" sector by -2.86% over the past year.
3088 vs Market: MatsukiyoCocokara & Co. has outperformed the market by 8.59% over the past year.
Stable price: 3088 is not significantly more volatile than the rest of the market on "Tokyo Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 3088 with weekly volatility of -0.0527% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (2376.5 Β₯) is higher than the fair price (1254.96 Β₯).
Price is higher than fair: The current price (2376.5 Β₯) is 47.2% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (19.27) is lower than that of the sector as a whole (111.01).
P/E vs Market: The company's P/E (19.27) is lower than that of the market as a whole (135.14).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.96) is lower than that of the sector as a whole (70.26).
P/BV vs Market: The company's P/BV (1.96) is lower than that of the market as a whole (103.82).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.9863) is lower than that of the sector as a whole (74.99).
P/S vs Market: The company's P/S indicator (0.9863) is lower than that of the market as a whole (104.62).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (8.79) is lower than that of the sector as a whole (17.9).
EV/Ebitda vs Market: The company's EV/Ebitda (8.79) is lower than that of the market as a whole (112.15).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 19.99% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (19.99%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-5.23%).
5.4. ROE
ROE vs Sector: The company's ROE (10.5%) is higher than that of the sector as a whole (-9.9%).
ROE vs Market: The company's ROE (10.5%) is higher than that of the market as a whole (8.46%).
5.5. ROA
ROA vs Sector: The company's ROA (7.41%) is higher than that of the sector as a whole (-10.11%).
ROA vs Market: The company's ROA (7.41%) is higher than that of the market as a whole (3.74%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (10.68%) is higher than that of the sector as a whole (9.09%).
ROIC vs Market: The company's ROIC (10.68%) is higher than that of the market as a whole (8.77%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 2.02% is below the average for the sector '2.69%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 2.02% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 2.02% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (25.32%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription